PL2361303T3 - Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki - Google Patents

Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki

Info

Publication number
PL2361303T3
PL2361303T3 PL09744160.4T PL09744160T PL2361303T3 PL 2361303 T3 PL2361303 T3 PL 2361303T3 PL 09744160 T PL09744160 T PL 09744160T PL 2361303 T3 PL2361303 T3 PL 2361303T3
Authority
PL
Poland
Prior art keywords
hgl
msc
kidney
preparing
stem cell
Prior art date
Application number
PL09744160.4T
Other languages
English (en)
Inventor
Giovanni Camussi
Stefania Bruno
Benedetta Bussolati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2361303T3 publication Critical patent/PL2361303T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0687Renal stem cells; Renal progenitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0668Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09744160.4T 2008-11-04 2009-11-02 Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki PL2361303T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08425708A EP2186883A1 (en) 2008-11-04 2008-11-04 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney

Publications (1)

Publication Number Publication Date
PL2361303T3 true PL2361303T3 (pl) 2016-10-31

Family

ID=40260686

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09744160.4T PL2361303T3 (pl) 2008-11-04 2009-11-02 Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki

Country Status (7)

Country Link
US (1) US9499796B2 (pl)
EP (2) EP2186883A1 (pl)
JP (1) JP5795737B2 (pl)
CN (1) CN102292434B (pl)
ES (1) ES2580172T3 (pl)
PL (1) PL2361303T3 (pl)
WO (1) WO2010052192A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2363136A1 (en) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
CN106214700B (zh) 2010-05-12 2021-09-07 因瑞金公司 生物活性肾细胞
JP2013536860A (ja) * 2010-08-31 2013-09-26 クック・ジェネラル・バイオテクノロジー・エルエルシー 動物の疾病の治療のための全身的、同種間幹細胞治療
CN103261407B (zh) * 2010-12-22 2016-03-02 杜兰教育基金委员会 用于识别和培养具有高度增殖潜能的多能间充质干细胞的方法
DK2729562T3 (en) 2011-07-06 2018-07-23 Cell Therapy Ltd Progenitor cells of mesodermal origin
BR112014007676A2 (pt) * 2011-09-30 2017-04-18 The Univ Of Miami células-tronco renais isoladas do rim
HUE046176T2 (hu) 2012-10-24 2020-02-28 Inregen Vesesejt-populációk és alkalmazásaik
WO2014113704A2 (en) 2013-01-18 2014-07-24 Escape Therapeutics, Inc. Enhanced differentiation of mesenchymal stem cells
CN104977414B (zh) * 2014-04-09 2016-09-28 上海交通大学医学院 鉴定骨髓中是否存在保护白血病干细胞微环境的试剂盒及其应用
CA2958533C (en) * 2014-08-21 2023-03-14 Ajinomoto Co., Inc. Culture medium for mesenchymal stem cells
US20180059109A1 (en) * 2016-08-31 2018-03-01 Meridigen Biotech Co., Ltd. Method of distinguishing mesenchymal stem cells and method of determining purity of mesenchymal stem cells
CN106265745A (zh) * 2016-09-30 2017-01-04 广州赛莱拉干细胞科技股份有限公司 一种干细胞制剂及其在制备治疗慢性肾炎的药物中的应用
JP7072777B2 (ja) * 2018-07-03 2022-05-23 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
CN117871216B (zh) * 2024-03-12 2024-06-04 中日友好医院(中日友好临床医学研究所) 一种石蜡标本中肾小球裂隙膜的三维可视化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4085410B2 (ja) * 2003-03-14 2008-05-14 株式会社 バイオリンクインク 腎臓幹細胞/前駆細胞、腎臓幹細胞/前駆細胞の分離方法、及び腎疾患の治療方法
ITFI20060099A1 (it) * 2006-04-28 2007-10-29 Azienda Ospedaliera Careggi Popolazione di cellule staminali renali, sua identificazione ed uso per finalita' terapeutiche
US10500230B2 (en) * 2006-10-12 2019-12-10 DePuy Synthes Products, Inc. Kidney-derived cells and methods of use in tissue repair and regeneration

Also Published As

Publication number Publication date
WO2010052192A1 (en) 2010-05-14
CN102292434A (zh) 2011-12-21
JP2012507304A (ja) 2012-03-29
EP2361303A1 (en) 2011-08-31
US20110256111A1 (en) 2011-10-20
US9499796B2 (en) 2016-11-22
EP2361303B1 (en) 2016-04-06
CN102292434B (zh) 2014-03-12
EP2361303B8 (en) 2016-08-10
ES2580172T3 (es) 2016-08-19
JP5795737B2 (ja) 2015-10-14
EP2186883A1 (en) 2010-05-19

Similar Documents

Publication Publication Date Title
PL2361303T3 (pl) Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki
HK1247954A1 (zh) 由人類多能幹細胞產生間充質幹細胞的方法以及通過所述方法產生的間充質幹細胞
IL283597A (en) A pluripotent stem cell growth medium containing human serum and without a nutrient layer
EP2374871A4 (en) PLURIPOTENT STEM CELLS, PROCESS FOR PREPARING THE SAME, AND USES THEREOF
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
EP2545928A4 (en) PREPARATION OF CELLS CONTAINING MESENCHYMAL STEM CELLS AND PROCESS FOR PRODUCTION THEREOF
WO2010111409A3 (en) Pluripotent stem cells
GB0907978D0 (en) Multipotent adult stem cell population
PL2495302T3 (pl) Urządzenie biologiczne do ekstrakcji krwiotwórczych komórek macierzystych i mezenchymalnych komórek macierzystych z krwi obwodowej
EP2183358A4 (en) PROCESS FOR THE PREPARATION OF DERMAL PAPER TISSUE EMPLOYING MESENCHYMAL STEM CELLS
WO2009092005A3 (en) Methods of generating cardiomyocytes and cardiac progenitors and compositions
IL202401A0 (en) Methods for production and uses of multipotent cell populations, pluripotent cell populations, differentiated cell populations, and hiv -resistant cell populations
HK1246356A1 (zh) 微載體上的多能幹細胞培養
WO2010111659A8 (en) Tumor-initiating cells and methods for using same
WO2010014949A3 (en) Compositions comprising hepatocyte-like cells and uses thereof
EP2612911A4 (en) COMPOSITION FOR THE INDUCTION OF PLURIPOTENTER STEM CELLS AND THEIR USE
EP2484336A4 (en) PIGMENT FOR COSMETICS PREPARATIONS, METHOD FOR THE PRODUCTION THEREOF, AND COSMETICS PREPARATION WITH THE PIGMENT FOR COSMETICS PREPARATIONS
EP2295537A4 (en) HUMAN HEPATIC STRAIN CELL, PREPARATION METHOD THEREFOR, METHOD OF INDUCING ITS DIFFERENTIATION AND METHOD OF USE
GB0918615D0 (en) Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
WO2011032025A3 (en) Adipose-derived induced pluripotent stem cells
ZA201201011B (en) Process for preparing levosimendan and intermediates for use in the process
EP2610337A4 (en) MASS TEST OF BLOOD CELL BLOOD CELLS USING CELL COAGULATION, ADULT BLOOD STEM CELLS USING THE SAME, METHOD OF EXPANDING PROGENITOR CELLS AND STEM CELLS PRODUCED USING THE METHOD
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
PH12012500315A1 (en) Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same
EP2380973A4 (en) PREPARATION BASED ON REPROGRAMMABLE CELL SIGNALING STEM CELLS, METHOD OF MAKING THE PREPARATION AND USE THEREOF